Skip to main content
SpringerLink
Log in

Erythropoietin in sports: a new look at an old problem

  • Published:
Current Sports Medicine Reports

Abstract

Erythropoietin (EPO) is found naturally in the human body and has been commercially available as recombinant human EPO (rEPO) for almost 20 years. Although the positive benefits of rEPO cannot be denied for those who suffer from anemia, athletes have also used the drug as an ergogenic aid. It has replaced conventional "blood doping" as the drug of choice to improve performance in contests requiring aerobic potential. Testing for the drug in the past has proven difficult due to several factors. The similarities in structure and metabolism of EPO and rEPO allow those who choose to abuse rEPO to avoid detection. Due to the inherent danger of abusing rEPO and its analogues, the various governing bodies of international sports continue to improve testing methods for this illegal substance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. ABC News. http://abcnews.go.com/Sports/ESPNSports/ story?id=246308

  2. Daily Nation on the web. http://www.nationaudio.com/News/ DailyNation/03092003/Sports/SportsO.html

  3. Kamber M: Fight against doping-national and international developments after Tour de France 1998. Ther Umsch 2001, 58:220–225.

    Article  CAS  PubMed  Google Scholar 

  4. Leigh-Smith S: Blood boosting. Br J Sports Med 2004, 38:99–101.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Joyner MJ: V02MAX, blood doping, and erythropoietin. Br J Sports Med 2003, 37:190–191.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Sawka MN, Joyner MJ, Miles DS, et al: American College of Sports Medicine position stand: the use of blood doping as an ergogenic aid. Med Sci Sports Exerc 1996, 28:i-viii. An excellent review of the literature on blood doping and EPO with several studies on ergogenic properties and methods of detection. This position stand by the American College of Sports Medicine discusses physiology, ergogenic benefits and risks of using EPO, and is a useful summary article.

    Article  CAS  Google Scholar 

  7. Miyake T, Kung CK, Goldwasser E: Purification of human erythropoietin. J Bid Chem 1977, 252:5558–5564.

    CAS  Google Scholar 

  8. Denker B: Erythropoietin: From Bench to Bedside. Nephrology Rounds. Volume 2, http://www.nephrologyrounds.org-March 2004. A detailed article reviewing the history, physiology, and pharmacology of EPO and rEPO. This article is most helpful in reviewing erythropoiesis as well as the dosing and pharmacokinetics of rEPO.

  9. National Center for Biotechnology Information. Online mendelian inheritance in man: genemap. http://www.ncbi.nlm.nih.gov/ entrez/queryfcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=2056

  10. Beris P: Erythropoietin and erythropoiesis. Haematologica 1998, 1:126–131.

    Google Scholar 

  11. Reikes ST, Martin KJ: Renal failure. In Textbook of Primary Care Medicine, edn 3. Edited by Noble J. St. Louis: Mosby; 2001:1395–1402.

    Google Scholar 

  12. Graber SE, Krantz SB: Erythropoietin and the control of red cell production. Ann Rev Med 1978, 29:51–66.

    Article  CAS  PubMed  Google Scholar 

  13. Eschbach JW, Egrie JC, Downing MR, et al: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987,316:73–78.

    Article  CAS  PubMed  Google Scholar 

  14. Eschbach JW, Abdulhadi MH, Browne JK, et al: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989, 111:992–1000.

    Article  CAS  PubMed  Google Scholar 

  15. Berglund B, Ekblom B: Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991, 229:125–130.

    Article  CAS  PubMed  Google Scholar 

  16. Lundin AP, Akerman MJ, Chesler RM, et al: Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 1991, 58:315–319.

    Article  CAS  PubMed  Google Scholar 

  17. Birkeland KI, Stray-Gundersen J, Hemmersbach P, et al: Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exer 2000, 32:1238–1243.

    Article  CAS  Google Scholar 

  18. Ekblom B, Berglund B: Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1991, 1:88–93.

    Article  Google Scholar 

  19. Pascual JA, Belalcazar V, de Bolos C, et al: Recombinant erythropoietin and analogues: a challenge for doping control. Ther Drug Monit 2004, 26:175–179. An interesting article reviewing recent approaches to rEPO detection with indirect serum markers, urine analysis, and future methods of testing for EPO and its analogues.

    Article  CAS  PubMed  Google Scholar 

  20. Wide L, Bengtsson C, Berglund B, Ekblom B: Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 1995, 27:1569–1576.

    Article  CAS  PubMed  Google Scholar 

  21. Kazlauskas R, Howe C, Trout G: Strategies for rhEPO detection in sport. Clin J Sport Med 2002, 12:229–235.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Children’s Hospital of Iowa, 200 Hawkins Drive, 52242, Iowa City, IA, USA

    George C. Phillips MD, FAAP

Authors
  1. Joshua Scott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George C. Phillips MD, FAAP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scott, J., Phillips, G.C. Erythropoietin in sports: a new look at an old problem. Curr Sports Med Rep 4, 224–226 (2005). https://doi.org/10.1007/s11932-005-0040-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11932-005-0040-6

Keywords

Search

Navigation